posteditor

B Report highlights Kyndryl’s modernization capabilities and AI-enabled models that help enterprises advance their mainframe strategies. NEW YORK, April 20, 2026 /PRNewswire/ — Kyndryl (NYSE:… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B A single run in the bottom of the seventh inning cost Coffee County softball in Tullahoma Sunday. Scoreless through the first six innings of… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B The saucy chicken chain is serving up three bold wrap flavors alongside the return of its beloved Banana Pudding Milkshake – only for a… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

Co-written with Grammy Award-winning producer, engineer, and songwriter Jon Ingoldsby, “Iconic” blends soulful R&B vocals with gritty rock energy and infectious pop hooks. Pre-Save /… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B — A new, free Masterclass series built on a biblically inspired world-class benchmarking and management excellence “Framework” — WASHINGTON, April 20, 2026 /PRNewswire/ — Khachkar… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B The company highlights its approach to integrating real-time data analytics with automated PCR infrastructure The standalone booth features STAgora simulation and an interactive touchscreen… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B TORONTO, April 20, 2026 /PRNewswire/ – Woodway Assurance is unveiling a new EviData™ feature designed to help organizations better understand, assess and address anonymization… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Mackenzie to leverage OneVest’s highly configurable platform to launch a modern suite of advisor, investor, and onboarding solutions. TORONTO, April 20, 2026 /PRNewswire/ –… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B New Evidence Indicates Inflammation May Be the Cause of Cardiovascular Disease. A New Drug May be the Answer NEW YORK, April 20, 2026 /PRNewswire/… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for relapsed/refractory multiple myeloma with clinical data… Login to continue reading Login Sign up for complimentary access Sign Up Now Close